Six deaths linked to concomitant use of buprenorphine and benzodiazepines

Addiction

Volumn 93, Issue 9, 1998, Pages 1385-1392

  Reynaud, Michel ^a,b   Petit, Georges ^a   Potard, Denis ^a   Courty, Pascal ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b Hopital Saint Jacques Clermont Ferrand   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG ABUSE; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG FATALITY; DRUG LIVER LEVEL; DRUG TISSUE LEVEL; DRUG URINE LEVEL; FRANCE; HUMAN; MALE; OPIATE ADDICTION;

EID: 0031655824     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1360-0443.1998.93913859.x     Document Type: Article

References (54)

1. HEEL, R. C., BROGDEN, R. N., SPEIGHT, T. M. & AVERY, G. S. (1979) Buprenorphine: a review of its pharmacological properties and therapeutic efficacy, Drugs, 17, 81-110.
2. ARNOULD, J. F. & PINAUD, M. (1991) Pharmacologie de la buprénorphine 'Pharmacology of buprenorphine', Annales Françaises d'Anesthésie Réanimation, 10, 559-564.
3. WALSH, S. L., PRESTON, K. L., STITZER, M. L., CONE, E. J. & BIGELOW, G. E. (1994) Clinical pharmacology of buprenorphine: ceiling effects at high doses, Clinical Pharmacology and Therapeutics, 55, 569-580.
4. WALSH, S. L., PRESTON, K. L., BIGELOW, G. E. & STITZER, M. L. (1995) Acute administration of buprenorphine in humans: partial agonist and blockade effects, Journal of Pharmacology and Experimental Therapeutics, 274, 361-372.
5. BEAUVERIE, P., KHAN, B., GHALEH, B., VAN DE VYVER, M., POISSON, N. & JACQUOT, C. (1994) Pharmacodynamie comparée de la méthadone, de la buprénorphine et de la codéine [Pharmacodynamy of methadone, buprenorphine and codeine], Annales de Médecine Interne, 145 (suppl. 3), 15-18.
6. CIRCULAR, 31 March 1995, European Health Directorate.
7. CIRCULAR, 3 April 1996, European Health Directorate.
8. TRACQUI, A., KINTZ, P. & MANGIN, P. (1997) HPLC/MS determination of buprenorphine and norbuprenorphine in biological fluids and hair samples, Journal of Forensic Science, 42, 112-115.
9. DEBRABANDERE, VAN BOVEN, M. & DAENENS, P. (1993) Development of a radioimmunoassay for the determination of buprenorphine in biological samples, Analyst, 118, 137-143.
10. KINTZ, P., CIRIMELE, V., EDEL, Y., JAMEY, C. & MANGIN, P. (1994) Hair analysis for buprenorphine and its dealkylated metabolite by RIA and confirmation by LC/ECD, Journal of Forensic Science, 39, 1497-1503.
11. BLOM, Y. & BONDESSON, U. (1985) Analysis of buprenorphine and its N-dealkylated metabolite in plasma and urine by selected ion monitoring, Journal of Chromatography, 338, 89-98.
12. BERTHAULT, F., KINTZ, P. & MANGIN, P. (1998) Simultaneous high-performance liquid chromatography analysis of flunitrazcpam and four metabolites in serum, Journal of Chromatography, in press.
13. TRACQUI, A., KINTZ, P. & MANGIN, P. (1995) Systematic toxicological analysis using HPLC/ DAD, Journal of Forensic Science, 40, 112-120.
14. MCQUAY, H. J., BULLINGHAM, R. E. S., BENNETT, M. R. D. & MOORE, R. A. (1979) Delayed respiratory depression. A case report and a new hypothesis, Acta Anaesthesiologia Belgium, 30 (suppl.), 245-247.
15. THȮRN, S. E., RAWAL, N. & WENNHAGER, M. (1988) Prolonged respiratory depression caused by sublingual buprenorphine, Lancet, 179-180.
16. ADRIANSEN, H., MATTELAER, B. & VANMEENEN, H. (1985) A long-term open, clinical and pharmacokinetic assessment of sublingual buprenorphine in patients suffering from chronic pain, Acta Anaesthesiologica, Belgium, 36, 33-40.
17. BULLINGHAM, R. E. S., MCQUAY, H. J., MOORE, A. & BENNETT, M. R. D. (1980) Buprenorphine kinetics, Clinical Pharmacology and Therapeutics, 28, 667-672.
18. BULLINGHAM, R. E. S., MCQUAY, H. J., PORTER, E. J. B., ALLEN, M. C. & MOORE, R. A. (1982) Sublingual buprenorphine used postoperatively: ten hour plasma drug concentration analysis, British Journal of Clinical Pharmacology, 13, 665-673.
19. LEHMANN, K. A., REICHLING, U. & WIRTZ, R. (1988) Influence of naloxone on the postoperative analgesic and respiratory effects of buprenorphine, European Journal of Clinical Pharmacology, 34, 343-352.
20. COWAN, A. & LEWIS, J. W. (1995) Buprenorphine. Combating drug abuse with a unique opioid, pp. 113-135 (New York, John Wiley).
21. POUNDER, D. J. & JONES, G. R. (1990) Post-mortem redistribution - a toxicological nightmare, Forensic Science International, 45, 253-263.
22. L'AUTOPSIE MÉDICOLÉGALE EN FRANCE [French forensic autopsy] (1996), Médecine et Droit, 20, 15-19.
23. TRACQUI, A. & LUDES, B. (1996) De l'autopsie au prélévement [From autopsy to sample], Pharmacologie et Toxicologie Médico-légales, 53-58.
24. PONTANI, R. B., VADLAMANI, N. L. & MISRA, A. L. (1985) Disposition in the rat of buprenorphine administered parenterally and as a subcutaneous implant, Xenobiotica, 15, 287-297.
25. ZENZ, M., PIEPENBROCK, S., TRYBA, M., GLOCKE, M., EVERLIEN, M. & KLAUKE, W. (1985) Langzeittherapie von Krebsschmerzen. Kontrollierte Studie mit Buprenorphin [Long time therapy of tumor pain. A controlled study with buprenorphine], Deutsche Medizinische Wochenschrift, 110, 448-453.
26. BANKS, C. D. (1979) Overdosage of buprenorphine: case report, New Zealand Medical Journal, 89, 255-256.
27. JAIN, P. N. & SHAH, S. C. (1983) Respiratory depression following combination of epidural buprenorphine and intramuscular ketorolac, Anaesthesia, 48, 898-899.
28. KNAPE, J. T. A. (1986) Early respiratory depression resistant to naloxone following epidural buprenorphine, Anesthesiology, 64, 382-384.
29. MARTEGANI, G., VARESIO, V. & AGOSTA, I. (1987) Segnalazione di un caso di depressione respiratoria riferibile all'impiego di buprenorfina per via peridurale [A case of respiratory depression linked to the use of intraspinal buprenorphine], Minerva Anestesiologia, 53, 141-143.
30. ADELHOJ, B., PETRING, O. U., IBSEN, M., BRYNNUM, J. & POULSEN, H. E. (1985) Et tilfaelde hos en yngre rask mand [Tardive respiratory depression after intravenous buprenorphine], Ugeskr Laeger, 147, 1343.
31. FAROQUI, M. H., COLE, M. & CURRAN, J. (1983) Buprenorphine, benzodiazepines and respiratory depression, Anaesthesia, 38, 1002-1003.
32. FORREST, A. L. (1983) Buprenorphine and lorazepam, Anaesthesia, 38, 598.
33. GIBBS, J. M., JOHNSON, H. D. & DAVIS, F. M. (1982) Patient administration of i.v. buprenorphine for postoperative pain relief using the 'Cardiff' demand analgesia apparatus, British Journal of Anaesthesiology, 54, 279-284.
34. PAPWORTH, D. P. (1983) High dose buprenorphine for postoperative analgesia, Anaesthesia, 38, 163.
35. SCHMIDT, J. F., CHRAEMMER-JORGENSEN, B., PEDERSEN, J. E. & RISBO, A. (1985) Postoperative pain relief with naloxone. Severe respiratory depression and pain after high dose buprenorphine, Anaesthesia, 40, 583-586.
36. SEKAR, M. & MIMPRISS, T. I. (1987) Buprenorphine, benzodiazépines and prolonged respiratory depression, Anaesthesia, 42, 567-568.
37. TIXIER-WULFF, S. & JOURDAN, C. (1992) Insuffisance respiratoire aiguë tardive après injection de buprénorphine [Tardive respiratory depression after buprenorphine injection], Annales Françaises d'Anesthésie Réanimation, 11, 240-241.
38. MOLKE JENSEN, F., JENSEN, N. H., HOLK, I. K. & RAVNDORG, M. (1987) Prolonged and biphasic respiratory depression following epidural buprenorphine, Anaesthesia, 42, 470-475.
39. COOK, P. J., JAMES, I. M., HOBBS, K. E. F. & BROWNE, D. R. G. (1982) Controlled comparison of i.m. morphine and buprenorphine for analgesia after abdominal surgery, British Journal of Anaesthesiology, 54, 285-290.
40. DOWNING, J. W., GOODWIN, N. M. & HICKS, J. (1979) The respiratory dépressive effects of intravenous buprenorphine in patients in an intensive care unit, South Africa Medical Journal, 55, 1023-1027.
41. KAY, B. & POLLARD, B. J. (1988) L'almitrine supprime temporairement la dépression respiratoire causée par la buprénorphine [Almitrine temporarily suppresses the respiratory depression caused by buprenorphine], Annales Françaises d'Anesthésie Réanimation, 7, 176-177.
42. WATSON, P. J. Q., MCQUAY, H. J., BULLINGHAM, R. E. S., ALLEN, M. C. & MOORE, R. A. (1982) Single dose comparison of buprenorphine 0.3 and 0.6 mg i.v. given after operation: clinical effects and plasma concentrations, British Journal Anaesthesiology, 54, 37-43.
43. KAA, E. & TEIGE, B. (1993) Drug-related deaths during the 1980s. A comparative study of drug addict deaths examined at the institutes of forensic medicine in Aarhus, Denmark and Oslo, Norway, International Journal of Legal Medicine, 106, 5-9.
44. CASSIDY, M. T. (1995) Drug abuse deaths in Glasgow in 1992 - a retrospective study, Medical Science Law, 35, 207-212.
45. HAMMERSLEY, R. (1995) Drugs associated with drug-related deaths in Edinburgh and Glasgow, November 1990 to October 1992, Addiction, 90, 959-965.
46. PACH, J. (1995) Acute poisonings with drugs of abuse, Przeglad Lekarski, 52, 275-280.
47. MARTIN, J. (1996) Utilisation abusive du flunitrazépam (Rohypnol) par les toxicomanes [Abuse of nitrazepam (Rohypnol) by drug addicts], Prescrire, 16, 376-377.
48. PEZOUS, A. M. & SCHMITT, L. (1994) Drogues [Drugs], Revue du Praticien, 44, 689-698.
49. RICHARD, D. & COLLARD, C. (1991) Toxicomanies: les divers types de dépendances [Drugs addictions: different dependences], Moniteur Internat, 25, 97-106.
50. ACUTE REACTIONS TO DRUGS OF ABUSE (1996) Medical Letter, 38, 43-46.
51. GIBBS, J. M. (1984) Sedatives, narcotics and antipsychotics, Clinical Anaesthesiology, 2/3, 605-617.
52. BERTSCHY, G. (1995) Pourquoi et comment éviter de prescrire du flunitrazépam (Rohypnol) au toxicomane? [How and why avoid flunitrazepam prescription to drug addicts], Médecine et Hygiène, 53, 1861-1864.
53. TRACQUI, A., KINTZ, P. & MANGIN, P. (1998) Intoxications aiguës par dextropropoxyphcne: a propos de 22 décès [Dextropropoxyphene poisoning], Journal de Médecine Légale et de Droit Médical, in press.
54. THAMMAKUMPEE, G. & SUMPATANUKULE, P. (1994) Noncardiogenic pulmonary edema induced by sublingual buprenorphine, Chest, 106, 306-308.